Clindamycin (clindamycin phosphate) NDC 0404-9838

NDC codes

FDA NDC Directory

Product NDC (as listed)0404-9838Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00404-9838Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0404-9838-04	00404983804	1 VIAL in 1 BAG (0404-9838-04) / 4 mL in 1 VIALMarketed from Jan 9, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 150 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Henry Schein, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090108
Marketing start: Jan 9, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 0404-9838_818d5172-0214-4204-b2e6-6266ce15e8e6SPL ID 818d5172-0214-4204-b2e6-6266ce15e8e6SPL set ID 8a4e2ba4-90e6-48e8-a943-0c5d3f169780RxCUI 1737244, 1737578, 1737581UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400404983804 followed by a unit qualifier and the quantity

Package 00404-9838-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 18, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin Injection, USP is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin Injection, USP is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibiotic-associated pseudomembranous colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090108

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090108
Product	Strength	Form · route	Labeler	Product NDC
Clindamycinclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7191
Clindamycinclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7192
Clindamycinclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7284
Clindamycinclindamycin phosphate	Clindamycin phosphate 150 mg/mL	Injection, SolutionIntramuscular, Intravenous	Sagent Pharmaceuticals	25021-115